SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Broeckling Corey) "

Sökning: WFRF:(Broeckling Corey)

  • Resultat 1-10 av 14
  • [1]2Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Broeckling, Corey D., et al. (författare)
  • Assigning precursor-product ion relationships in indiscriminant MS/MS data from non-targeted metabolite profiling studies
  • 2013
  • Ingår i: Metabolomics. - 1573-3882 .- 1573-3890. ; 9:1, s. 33-43
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Tandem mass spectrometry using precursor ion selection (MS/MS) is an invaluable tool for structural elucidation of small molecules. In non-targeted metabolite profiling studies, instrument duty cycle limitations and experimental costs have driven efforts towards alternate approaches. Recently, researchers have begun to explore methods for collecting indiscriminant MS/MS (idMS/MS) data in which the fragmentation process does not involve precursor ion isolation. While this approach has many advantages, importantly speed, sensitivity and coverage, confident assignment of precursor-product ion relationships is challenging, which has inhibited broad adoption of the technique. Here, we present an approach that uses open source software to improve the assignment of precursor-product relationships in idMS/MS data by appending a dataset-wide correlational analysis to existing tools. The utility of the approach was demonstrated using a dataset of standard compounds spiked into a malt-barley background, as well as unspiked human serum. The workflow was able to recreate idMS/MS spectra which are highly similar to standard MS/MS spectra of authentic standards, even in the presence of a complex matrix background. The application of this approach has the potential to generate high quality idMS/MS spectra for each detectable molecular feature, which will streamline the identification process for non-targeted metabolite profiling studies.</p>
  •  
2.
  • Ganna, Andrea, et al. (författare)
  • Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease
  • 2014
  • Ingår i: PLOS Genetics. - 1553-7390 .- 1553-7404. ; 10:12
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Analyses of circulating metabolites in large prospective epidemiological studies could lead to improved prediction and better biological understanding of coronary heart disease (CHD). We performed a mass spectrometry-based non-targeted metabolomics study for association with incident CHD events in 1,028 individuals (131 events; 10 y. median follow-up) with validation in 1,670 individuals (282 events; 3.9 y. median follow-up). Four metabolites were replicated and independent of main cardiovascular risk factors [lysophosphatidylcholine 18∶1 (hazard ratio [HR] per standard deviation [SD] increment = 0.77, P-value&lt;0.001), lysophosphatidylcholine 18∶2 (HR = 0.81, P-value&lt;0.001), monoglyceride 18∶2 (MG 18∶2; HR = 1.18, P-value = 0.011) and sphingomyelin 28∶1 (HR = 0.85, P-value = 0.015)]. Together they contributed to moderate improvements in discrimination and re-classification in addition to traditional risk factors (C-statistic: 0.76 vs. 0.75; NRI: 9.2%). MG 18∶2 was associated with CHD independently of triglycerides. Lysophosphatidylcholines were negatively associated with body mass index, C-reactive protein and with less evidence of subclinical cardiovascular disease in additional 970 participants; a reverse pattern was observed for MG 18∶2. MG 18∶2 showed an enrichment (P-value = 0.002) of significant associations with CHD-associated SNPs (P-value = 1.2×10-7 for association with rs964184 in the ZNF259/APOA5 region) and a weak, but positive causal effect (odds ratio = 1.05 per SD increment in MG 18∶2, P-value = 0.05) on CHD, as suggested by Mendelian randomization analysis. In conclusion, we identified four lipid-related metabolites with evidence for clinical utility, as well as a causal role in CHD development.</p>
  •  
3.
  • Hong, Mun-Gwan, et al. (författare)
  • A genome-wide assessment of variability in human serum metabolism
  • 2013
  • Ingår i: Human Mutation. - 1059-7794 .- 1098-1004. ; 34:3, s. 515-524
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>The study of the genetic regulation of metabolism in human serum samples can contribute to a better understanding of the intermediate biological steps that lead from polymorphism to disease. Here, we conducted a genome-wide association study (GWAS) to discover metabolic quantitative trait loci (mQTLs) utilizing samples from a study of prostate cancer in Swedish men, consisting of 402 individuals (214 cases and 188 controls) in a discovery set and 489 case-only samples in a replication set. A global nontargeted metabolite profiling approach was utilized resulting in the detection of 6,138 molecular features followed by targeted identification of associated metabolites. Seven replicating loci were identified (PYROXD2, FADS1, PON1, CYP4F2, UGT1A8, ACADL, and LIPC) with associated sequence variants contributing significantly to trait variance for one or more metabolites (P = 10(-13) -10(-91)). Regional mQTL enrichment analyses implicated two loci that included FADS1 and a novel locus near PDGFC. Biological pathway analysis implicated ACADM, ACADS, ACAD8, ACAD10, ACAD11, and ACOXL, reflecting significant enrichment of genes with acyl-CoA dehydrogenase activity. mQTL SNPs and mQTL-harboring genes were over-represented across GWASs conducted to date, suggesting that these data may have utility in tracing the molecular basis of some complex disease associations.</p>
  •  
4.
  • Kumar, Jitender, et al. (författare)
  • Associations of Body Mass Index and Obesity-Related Genetic Variants with Serum Metabolites
  • 2014
  • Ingår i: Current Metabolomics. - 2213-235X. ; 2:1, s. 27-36
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Objectives: Body mass index (BMI) is one of the most important risk factors for different metabolic and cardiovascular disorders. Previously, both genetic and environmental agents associated with BMI have been described. The main focus of this exploratory study was to find the circulating metabolites associated with BMI utilizing an untargeted metabolomics approach. Additionally, significant metabolites identified were studied for their relation with BMIassociated single nucleotide polymorphisms (SNPs). Materials and Methods: A total of 971 individuals from the Cancer of the Prostate in Sweden study (discovery sample- 275 prostate cancers patients and 182 controls; replication sample- 514 prostate cancer patients) were utilized. Blood samples were collected and serum metabolic profiling was obtained using ultra-performance liquid chromatography followed by mass spectrometry. Genotyping data was available for 26 out of 32 SNPs (21 genotyped and 5 proxies) previously robustly associated with BMI in individuals of European descent. Weighted genetic risk score was generated using these SNPs and studied for its association with metabolites. Results: A total of 6138 and 5209 metabolite features were detected in discovery and replication samples, respectively. Out of 6138 metabolite features in discovery sample, 201 were found to be significantly associated with BMI (p&lt;8.15*10-6) after multiple testing correction. These 201 features were further investigated in the replication samples and 16 were found to be significantly associated with BMI (p&lt;2.49*10-4). Seven of these significant features were isotopes for four of the primary metabolites. Four metabolites were putatively identified: monoacylglyceride (18:1), diacylglyrcerol (32:1) and two phosphatidylcholines (34:0 and 36:0). Weighted genetic score of BMI-associated SNPs was not associated with these four metabolites. Conclusion: Four identifiable metabolites (monoacylglyceride, diacyclglyrcerol and two phosphatidylcholines) were found to be significantly associated with BMI in both discovery and replication samples. Common variants associated with BMI did not show association with these four metabolites. - See more at: http://www.eurekaselect.com/120422/article#sthash.PgqffHqv.dpuf</p>
  •  
5.
  • Kumar, Jitender, et al. (författare)
  • Influence of Biological and Technical Covariates on Non-targeted Metabolite Profiling in a Large-scale Epidemiological Study
  • 2013
  • Ingår i: Current Metabolomics. - 2213-235X. ; 1:3, s. 220-226
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Non-targeted metabolite profiling using ultra performance liquid chromatography-mass spectrometry (UPLCMS) was performed as part of a large-scale epidemiological study involving biobanked serum samples. The influence of both biological (age and body mass index) and technical (season of sample collection, fasting time, handling time, and storage time) covariates on the analysis was assessed. Statistical models including different sets of these covariates were compared and the results illustrate that variation in which covariates were included did not have an appreciable effect on the number or composition of biologically significant metabolite features associated with body mass index or age. Furthermore, when all covariates were included in the model, there was little overlap of metabolite features significantly associated with the different covariates. Thus, the results of this study illustrate that while some of the observed quantitative variance of metabolite features can be explained by biological and technical covariates, the use of non-targeted metabolite profiling of serum by UPLC-MS is valid for studies of biological outcomes in biobanked clinical samples from large-scale studies. - See more at: http://www.eurekaselect.com/115259/article#sthash.BOvtwWe7.dpuf</p>
  •  
6.
  • Lind, Lars, et al. (författare)
  • A Multi-Cohort Metabolomics Analysis Discloses Sphingomyelin (32:1) Levels to be Inversely Related to Incident Ischemic Stroke
  • 2019
  • Ingår i: Journal of Stroke & Cerebrovascular Diseases. - 1052-3057 .- 1532-8511. ; 29:2
  • Tidskriftsartikel (refereegranskat)abstract
    • <p><strong>BACKGROUND AND PURPOSE:</strong> To search for novel pathophysiological pathways related to ischemic stroke using a metabolomics approach.</p><p><strong>METHODS:</strong> We identified 204 metabolites in plasma by liquid chromatography mass spectrometry in 3 independent population-based samples (TwinGene, Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) and Uppsala Longitudinal Study of Adult Men). TwinGene was used for discovery and the other 2 samples were meta-analyzed as replication. In PIVUS, traditional cardiovascular (CV) risk factors, multiple markers of subclinical CV disease, markers of coagulation/fibrinolysis were measured and analyzed in relation to top metabolites.</p><p><strong>RESULTS:</strong> In TwinGene (177 incident cases, median follow-up 4.3 years), levels of 28 metabolites were associated with incident ischemic stroke at a false discover rate (FDR) of 5%. In the replication (together 194 incident cases, follow-up 10 and 12 years, respectively), only sphingomyelin (32:1) was significantly associated (HR .69 per SD change, 95% CI .57-0.83, P value = .00014; FDR &lt;5%) when adjusted for systolic blood pressure, diabetes, smoking, low density lipoportein (LDL)- and high density lipoprotein (HDL), body mass index (BMI) and atrial fibrillation. In PIVUS, sphingomyelin (32:1) levels were significantly related to both LDL- and HDL-cholesterol in a positive fashion, and to serum triglycerides, BMI and diabetes in a negative fashion. Furthermore, sphingomyelin (32:1) levels were related to vasodilation in the forearm resistance vessels, and inversely to leukocyte count (P &lt; .0069 and .0026, respectively).</p><p><strong>CONCLUSIONS:</strong> An inverse relationship between sphingomyelin (32:1) and incident ischemic stroke was identified, replicated, and characterized. A possible protective role for sphingomyelins in stroke development has to be further investigated in additional experimental and clinical studies.</p>
  •  
7.
  • Lind, Lars, et al. (författare)
  • A Multi-Cohort Metabolomics Analysis Discloses Sphingomyelin (32:1) Levels to be Inversely Related to Incident Ischemic Stroke
  • 2020
  • Ingår i: Journal of Stroke & Cerebrovascular Diseases. - 1052-3057 .- 1532-8511. ; 29:2
  • Tidskriftsartikel (refereegranskat)abstract
    • <p><strong>Background and Purpose:</strong></p><p>To search for novel pathophysiological pathways related to ischemic stroke using a metabolomics approach.</p><p><strong>Methods: </strong></p><p>We identified 204 metabolites in plasma by liquid chromatography mass spectrometry in 3 independent population-based samples (TwinGene, Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) and Uppsala Longitudinal Study of Adult Men). TwinGene was used for discovery and the other 2 samples were meta-analyzed as replication. In PIVUS, traditional cardiovascular (CV) risk factors, multiple markers of subclinical CV disease, markers of coagulation/fibrinolysis were measured and analyzed in relation to top metabolites.</p><p><strong>Results:</strong></p><p>In TwinGene (177 incident cases, median follow-up 4.3 years), levels of 28 metabolites were associated with incident ischemic stroke at a false discover rate (FDR) of 5%. In the replication (together 194 incident cases, follow-up 10 and 12 years, respectively), only sphingomyelin (32:1) was significantly associated (HR.69 per SD change, 95% CI.57-0.83, P value = .00014; FDR &lt;5%) when adjusted for systolic blood pressure, diabetes, smoking, low density lipoportein (LDL)- and high density lipoprotein (HDL), body mass index (BMI) and atrial fibrillation. In PIVUS, sphingomyelin (32:1) levels were significantly related to both LDL- and HDL-cholesterol in a positive fashion, and to serum triglycerides, BMI and diabetes in a negative fashion. Furthermore, sphingomyelin (32:1) levels were related to vasodilation in the forearm resistance vessels, and inversely to leukocyte count (P &lt; .0069 and .0026, respectively).</p><p><strong>Conclusions:</strong></p><p>An inverse relationship between sphingomyelin (32:1) and incident ischemic stroke was identified, replicated, and characterized. A possible protective role for sphingomyelins in stroke development has to be further investigated in additional experimental and clinical studies.</p>
  •  
8.
  • Nowak, Christoph, et al. (författare)
  • Effect of insulin resistance on monounsaturated fatty acid levels a multi-cohort non-targeted metabolomics and mendelian randomization study
  • 2016
  • Ingår i: PLoS Genetics. - 1553-7390 .- 1553-7404. ; 12:10
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Insulin resistance (IR) and impaired insulin secretion contribute to type 2 diabetes and cardiovascular disease. Both are associated with changes in the circulating metabolome, but causal directions have been difficult to disentangle. We combined untargeted plasma metabolomics by liquid chromatography/mass spectrometry in three non-diabetic cohorts with Mendelian Randomization (MR) analysis to obtain new insights into early metabolic alterations in IR and impaired insulin secretion. In up to 910 elderly men we found associations of 52 metabolites with hyperinsulinemic-euglycemic clamp-measured IR and/or β-cell responsiveness (disposition index) during an oral glucose tolerance test. These implicated bile acid, glycerophospholipid and caffeine metabolism for IR and fatty acid biosynthesis for impaired insulin secretion. In MR analysis in two separate cohorts (n = 2,613) followed by replication in three independent studies profiled on different metabolomics platforms (n = 7,824 / 8,961 / 8,330), we discovered and replicated causal effects of IR on lower levels of palmitoleic acid and oleic acid. A trend for a causal effect of IR on higher levels of tyrosine reached significance only in meta-analysis. In one of the largest studies combining "gold standard" measures for insulin responsiveness with non-targeted metabolomics, we found distinct metabolic profiles related to IR or impaired insulin secretion. We speculate that the causal effects on monounsaturated fatty acid levels could explain parts of the raised cardiovascular disease risk in IR that is independent of diabetes development.</p>
  •  
9.
  • Nowak, Christoph, et al. (författare)
  • Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance
  • 2018
  • Ingår i: Scientific Reports. - 2045-2322 .- 2045-2322. ; 8:1
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Insulin resistance (IR) predisposes to type 2 diabetes and cardiovascular disease but its causes are incompletely understood. Metabolic challenges like the oral glucose tolerance test (OGTT) can reveal pathogenic mechanisms. We aimed to discover associations of IR with metabolite trajectories during OGTT. In 470 non-diabetic men (age 70.6 ± 0.6 years), plasma samples obtained at 0, 30 and 120 minutes during an OGTT were analyzed by untargeted liquid chromatography-mass spectrometry metabolomics. IR was assessed with the hyperinsulinemic-euglycemic clamp method. We applied age-adjusted linear regression to identify metabolites whose concentration change was related to IR. Nine trajectories, including monounsaturated fatty acids, lysophosphatidylethanolamines and a bile acid, were significantly associated with IR, with the strongest associations observed for medium-chain acylcarnitines C10 and C12, and no associations with L-carnitine or C2-, C8-, C14- or C16-carnitine. Concentrations of C10- and C12-carnitine decreased during OGTT with a blunted decline in participants with worse insulin resistance. Associations persisted after adjustment for obesity, fasting insulin and fasting glucose. In mouse 3T3-L1 adipocytes exposed to different acylcarnitines, we observed blunted insulin-stimulated glucose uptake after treatment with C10- or C12-carnitine. In conclusion, our results identify medium-chain acylcarnitines as possible contributors to IR.</p>
  •  
10.
  • Nowak, Christoph, et al. (författare)
  • Metabolite profiles during an oral glucose tolerance test reveal new associations with clamp-measured insulin sensitivity
  • ????
  • Annan publikation (övrigt vetenskapligt)abstract
    • <p>Impaired insulin sensitivity (IS) is a major risk factor for cardiovascular disease and type 2 diabetes. Metabolomic profiling during an oral glucose tolerance test (OGTT) can reveal early pathogenic alterations in healthy individuals. Our aim was to identify IS biomarkers and gain new pathophysiologic insights by applying untargeted metabolomics to repeated OGTT plasma samples in association with a hyperinsulinemic-euglycemic clamp assessment. We studied 192 metabolites identified by non-targeted liquid chromatography/mass spectrometry in plasma samples taken at 0, 30, and 120 min during an OGTT in 470 non-diabetic 71-yr-old men. Insulin sensitivity was associated with 35 metabolites at one or more time points in multivariable-adjusted linear regression. The trajectories of nine metabolites during the OGTT were related to IS, six of which (oleic and palmitoleic acid, decanoyl- and dodecanoylcarnitine, deoxycholate-glycine and hexose) showed no associations with IS in the baseline fasting state. The strongest effects were detected for medium-chain acylcarnitines, which increased between 30-120 min in insulin-resistant individuals compared to those with normal IS. In this large community sample, we identified novel associations between clamp-measured IS and metabolite profiles that became apparent only after an oral glucose challenge. Associations of differential medium-chain acylcarnitine and monounsaturated fatty acid trajectories with IS provide new insights into the pathogenesis of insulin resistance.</p>
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 14
  • [1]2Nästa
Åtkomst
fritt online (5)
Typ av publikation
tidskriftsartikel (13)
annan publikation (1)
Typ av innehåll
refereegranskat (13)
övrigt vetenskapligt (1)
Författare/redaktör
Broeckling, Corey D. (13)
Ganna, Andrea (10)
Prenni, Jessica E. (10)
Ingelsson, Erik (9)
Salihovic, Samira, (9)
Lind, Lars, (6)
visa fler...
Ärnlöv, Johan, 1970- ... (5)
Fall, Tove (5)
Nowak, Christoph, (4)
Sundström, Johan, (3)
Wiklund, Fredrik (3)
Pedersen, Nancy L (3)
Prince, Jonathan A (3)
Magnusson, Patrik K. (3)
Magnusson, Patrik K ... (2)
Giedraitis, Vilmanta ... (2)
Lind, P. Monica, (2)
Karlsson, Robert, (2)
Hong, Mun-Gwan, (2)
Fall, Tove, 1979-, (2)
Ingelsson, Erik, 197 ... (2)
Kumar, Jitender, (2)
van Bavel, Bert (1)
Berne, Christian (1)
Siegbahn, Agneta, (1)
Larsson, Anders, (1)
Grönberg, Henrik (1)
Arnlov, Johan, (1)
Shen, Xia, (1)
Pawitan, Yudi (1)
Xu, Jianfeng (1)
Hedman, Asa K., (1)
Siegbahn, Agneta, 19 ... (1)
Sundström, Johan, Pr ... (1)
Ärnlöv, Johan, (1)
Salihovic, Samira, 1 ... (1)
van Bavel, Bert, 196 ... (1)
Cook, Naomi L., (1)
Sundstrom, Johan, (1)
Kärrman, Anna, (1)
Isaacs, William (1)
Brandmaier, Stefan, (1)
Heuberger, Adam L. (1)
Stenemo, Markus (1)
Castillejo-Lopez, Ca ... (1)
Lewis, Matthew R. (1)
Tukiainen, Taru (1)
Hyötyläinen, Tuulia (1)
Zheng, Lilly S (1)
Broeckling, Corey (1)
visa färre...
Lärosäte
Uppsala universitet (8)
Högskolan Dalarna (5)
Örebro universitet (1)
Språk
Engelska (13)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (13)
Naturvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy